Literature DB >> 22771536

Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway.

Olaf Hardt1, Stefan Wild, Ilka Oerlecke, Kay Hofmann, Shujun Luo, Yvonne Wiencek, Eva Kantelhardt, Christoph Vess, Geoffrey P Smith, Gary P Schroth, Andreas Bosio, Jürgen Dittmer.   

Abstract

We performed next generation sequencing- and microarray-based gene expression profiling of CD44(+)/CD24(-)/CD45(-) breast CSCs (cancer stem cells) isolated from primary ERα-positive breast cancer. By combining semi-automated dissociation of human tumor tissue, magnetic cell sorting and cDNA amplification less than 500 CSCs were required for transcriptome analyses. Besides overexpressing genes involved in maintenance of stemness, the CSCs showed higher levels of genes that drive the PI3K pathway, including EGFR, HB-EGF, PDGFRA/B, PDGF, MET, PIK3CA, PIK3R1 and PIK3R2. This suggests that, in CSCs of ERα-positive breast cancer, the PI3K pathway which is involved in endocrine resistance is hyperactive.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771536     DOI: 10.1016/j.canlet.2012.06.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  24 in total

Review 1.  Mechanisms of aromatase inhibitor resistance.

Authors:  Cynthia X Ma; Tomás Reinert; Izabela Chmielewska; Matthew J Ellis
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

2.  JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.

Authors:  Nicole D Facompre; Kayla M Harmeyer; Xavier Sole; Sheheryar Kabraji; Zachary Belden; Varun Sahu; Kelly Whelan; Koji Tanaka; Gregory S Weinstein; Kathleen T Montone; Alexander Roesch; Phyllis A Gimotty; Meenhard Herlyn; Anil K Rustgi; Hiroshi Nakagawa; Sridhar Ramaswamy; Devraj Basu
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

3.  Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.

Authors:  Arnaud Da Cruz Paula; Catarina Leitão; Oriana Marques; Ana Margarida Rosa; Ana Helena Santos; Alexandra Rêma; Maria de Fátima Faria; Ana Rocha; José Luís Costa; Margarida Lima; Carlos Lopes
Journal:  Virchows Arch       Date:  2017-01-23       Impact factor: 4.064

Review 4.  Research progress in breast cancer stem cells: characterization and future perspectives.

Authors:  Xiao-Dong Mao; Xiao Wei; Tao Xu; Tai-Ping Li; Kang-Sheng Liu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

5.  Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies.

Authors:  Ariella B Hanker; Adam D Pfefferle; Justin M Balko; María Gabriela Kuba; Christian D Young; Violeta Sánchez; Cammie R Sutton; Hailing Cheng; Charles M Perou; Jean J Zhao; Rebecca S Cook; Carlos L Arteaga
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

6.  A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.

Authors:  Shang-Hsun Tsou; Tzer-Ming Chen; Hui-Ting Hsiao; Yen-Hui Chen
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

7.  Genetic and epigenetic analysis of putative breast cancer stem cell models.

Authors:  Marija Balic; Daniela Schwarzenbacher; Stefanie Stanzer; Ellen Heitzer; Martina Auer; Jochen B Geigl; Richard J Cote; Ram H Datar; Nadia Dandachi
Journal:  BMC Cancer       Date:  2013-07-24       Impact factor: 4.430

Review 8.  Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer.

Authors:  Qinqin Li; Zhenghuan Rao; Yanlin Wang; Lei Zhang; Jing Chen; Runlan Wan; Alexander Tobias Teichmann
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

9.  Gastric stem cells and gastric cancer stem cells.

Authors:  Myoung-Eun Han; Sae-Ock Oh
Journal:  Anat Cell Biol       Date:  2013-03-25

10.  Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.

Authors:  Ilka Oerlecke; Elke Bauer; Angela Dittmer; Benjamin Leyh; Jürgen Dittmer
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.